List of Excipients in API neratinib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing neratinib
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Puma Biotechnology Inc | NERLYNX | neratinib | 70437-240 | CELLULOSE, MICROCRYSTALLINE | 2030-12-29 |
| Puma Biotechnology Inc | NERLYNX | neratinib | 70437-240 | CROSPOVIDONE | 2030-12-29 |
| Puma Biotechnology Inc | NERLYNX | neratinib | 70437-240 | FERRIC OXIDE RED | 2030-12-29 |
| Puma Biotechnology Inc | NERLYNX | neratinib | 70437-240 | MAGNESIUM STEARATE | 2030-12-29 |
| Puma Biotechnology Inc | NERLYNX | neratinib | 70437-240 | MANNITOL | 2030-12-29 |
| Puma Biotechnology Inc | NERLYNX | neratinib | 70437-240 | POLYETHYLENE GLYCOL | 2030-12-29 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for neratinib
Excipient focus: CELLULOSE, MICROCRYSTALLINE
neratinib drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Puma Biotechnology Inc | neratinib | 70437-240 |
| >Company | >Ingredient | >NDC |
neratinib drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
neratinib drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Puma Biotechnology Inc | neratinib | 70437-240 |
| >Company | >Ingredient | >NDC |
neratinib drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
neratinib drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Puma Biotechnology Inc | neratinib | 70437-240 |
| >Company | >Ingredient | >NDC |
neratinib drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
neratinib drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Puma Biotechnology Inc | neratinib | 70437-240 |
| >Company | >Ingredient | >NDC |
neratinib drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
neratinib drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Puma Biotechnology Inc | neratinib | 70437-240 |
| >Company | >Ingredient | >NDC |
neratinib drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
neratinib drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Puma Biotechnology Inc | neratinib | 70437-240 |
| >Company | >Ingredient | >NDC |
neratinib drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
neratinib drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Puma Biotechnology Inc | neratinib | 70437-240 |
| >Company | >Ingredient | >NDC |
neratinib drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
neratinib drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Puma Biotechnology Inc | neratinib | 70437-240 |
| >Company | >Ingredient | >NDC |
neratinib drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
neratinib drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Puma Biotechnology Inc | neratinib | 70437-240 |
| >Company | >Ingredient | >NDC |
neratinib drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
neratinib drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Puma Biotechnology Inc | neratinib | 70437-240 |
| >Company | >Ingredient | >NDC |
neratinib drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
neratinib drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Puma Biotechnology Inc | neratinib | 70437-240 |
| >Company | >Ingredient | >NDC |
neratinib drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
neratinib drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Puma Biotechnology Inc | neratinib | 70437-240 |
| >Company | >Ingredient | >NDC |
neratinib drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
